Devicare has announced the first round of investment in the healthcare and life sciences sector in Catalonia in 2021: €2.45 million from Asian Group Advanced MedTech Holdings, which specialises in medical technology for urology.

Other participants in the round include the company’s main partners, EMESA Capital, Joan Knuth and its founder Rosendo Garganta, plus Ship2B through the impact investment fund Equity4Good.

The funding will be used to develop the second generation of Lit-Control®, a non-invasive digitised treatment for kidney stones.

Abel Ang, CEO of Advanced MedTech, says, “We hope to expand the Devicare value proposal on a global scale.” Advanced MedTech is based in Singapore, has 8 subsidiaries (Germany, Spain, United States, France, Italy, Japan, Malaysia and China) and is present in 100 countries through its distribution network.

More information

Photo: Rosendo Garganta, founder and CEO of Devicare, a CataloniaBio & HealthTech member.

You may also be interested:

• Strategic agreement between Devicare and Idneo for Lit-Control® diagnostic devices
• Successful Ventures invests in Devicare
• Devicare announces the positive results of the clinical trial with Lit-Control® to prevent the encrustation of catheters